![Aucune image disponible](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1338545-07-5 - Thieno[2,3-c]quinolin-4(5H)-one, 9-[4-[(1R)-2-(dimethylamino)-1-methylethyl]phenyl]-8-hydroxy-6-methyl-, hydrochloride (1:1)
Formule :C23H24N2O2S.ClH
InChI :InChI=1S/C23H24N2O2S.ClH/c1-13-11-18(26)19(16-7-5-15(6-8-16)14(2)12-25(3)4)20-17-9-10-28-22(17)23(27)24-21(13)20;/h5-11,14,26H,12H2,1-4H3,(H,24,27);1H/t14-;/m0./s1
Code InChI :InChIKey=YHPWOYBWUWSJDW-UQKRIMTDSA-N
SMILES :Cl.O=C1NC=2C(=CC(O)=C(C=3C=CC(=CC3)C(C)CN(C)C)C2C=4C=CSC14)C
Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
---|---|---|---|---|
![]() | OTS964 REF : AN-AG009CJICAS : 1338545-07-5 | 98% | 47,00 €~588,00 € | jeu 11 Jul 24 |
![]() | OTS-964 REF : 54-BISN0160CAS : 1338545-07-5 | 99.1% (Typical Value in Batch COA) | 170,00 €~384,00 € | jeu 18 Jul 24 |
![]() | OTS964 hydrochloride REF : TM-T4135CAS : 1338545-07-5 | 98.02% | 45,00 €~510,00 € | jeu 18 Jul 24 |
![]() | OTS 964 REF : 3D-NDC54507CAS : 1338545-07-5 | Min. 95% | À demander | jeu 22 Aoû 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
OTS964
Ref: AN-AG009CJI
1mg | 47,00 € | ||
2mg | 66,00 € | ||
25mg | 177,00 € | ||
50mg | 215,00 € | ||
100mg | 486,00 € | ||
250mg | 588,00 € |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
OTS-964
Ref: 54-BISN0160
2mg | 170,00 € | ||
5mg | 277,00 € | ||
10mg | 384,00 € |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
OTS964 hydrochloride
- Inhibiteurs
- Apoptose
- Cycle cellulaire/point de contrôle
- CDK
- Voir plus de catégories
- TOPK
- MAPK
Ref: TM-T4135
1mg | 45,00 € | ||
2mg | 59,00 € | ||
5mg | 92,00 € | ||
10mg | 122,00 € | ||
25mg | 193,00 € | ||
50mg | 343,00 € | ||
100mg | 510,00 € | ||
1ml*10 (DMSO) | 95,00 € |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
OTS 964
Ref: 3D-NDC54507
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander | ||
100mg | À demander |